BioNTech counts on shift to cancer drugs after second quarter losses quadruple
LOSSES at German drugmaker BioNTech quadrupled in the second quarter from a year earlier, the company said on Monday (Aug ...
LOSSES at German drugmaker BioNTech quadrupled in the second quarter from a year earlier, the company said on Monday (Aug ...
Content warning: This story discusses murder and suicide. A 10-year-old boy woke up to "carnage" in his Oklahoma City home, ...
OCBC announced on Tuesday (Mar 26) that it expects to facilitate 250,000 cross-border QR payments this year, four times the ...
JAPAN’S Asahi Group Holdings is on the hunt for acquisition targets in the United States and elsewhere to quadruple overseas ...
Gerard Grech, CEO of Tech nationTech Nation Britain’s innovation ecosystem could quadruple in value between now and 2032 but only ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.